PM Portfolio Manager Reports

From Portfolio Manager reports

Conversion, Enrichment, HALEU, And Fuel Fabrication

This page covers the fuel-cycle steps after mined uranium leaves the feedstock stage: conversion changes uranium concentrate into chemical forms that enrichers can process, enrichment raises the uranium-235 concentration into low-enriched uranium (LEU) or high-assay low-enriched uranium (HALEU), and fuel fabrication turns enriched material into pellets, rods, assemblies, or specialized reactor fuel. The node matters because existing reactors and advanced designs cannot turn nuclear demand into megawatt-hours without qualified fuel supply. The ranked read is LEU first for direct U.S. enrichment and HALEU capacity, CCJ second for scaled conversion and fuel-services economics, BWXT third for fuel-adjacent nuclear manufacturing, ASPI fourth as a speculative U.S. enrichment tail, and Silex/GLE as an off-grid watch row because local chart coverage is missing.

Report boundary: this node is a tactical report layer. Durable company research stays in the linked knowledge pages. Price and volume context comes from read-only discovery daily_ohlc through 2026-06-12. SILXY / SLX.AX has no local discovery coverage in this checkout, so no API chart is attached to that watch row.

Current Setup

Fuel-cycle bottleneck Policy support only matters when fuel capacity becomes contracts and cash.

Conversion, enrichment, HALEU, and fabrication are licensed industrial steps. The node pays when SWU, conversion, fuel, or DOE work becomes funded capacity, delivered product, segment margin, backlog conversion, and operating cash flow.

Positive proof LEU has the cleanest public HALEU and U.S. enrichment route. CCJ adds real conversion and fuel-services revenue; BWXT adds nuclear manufacturing and fuel-adjacent fabrication.
Conversion gate Funding and delivery decide whether awards become economics. Watch DOE task-order terms, utility supply contracts, licensing, construction, segment margin, capex, and cash burn.
Primary constraint Capacity timelines are long and source coverage is uneven. ASPI and Silex/GLE remain tails until technology, licensing, offtake, funding, and delivery proof improves.
  1. Feedstock inputU3O8 and UF6 supply
  2. Industrial workConversion, SWU, HALEU
  3. Customer proofDOE and utility contracts
  4. Equity proofMargin, cash, backlog

Static setup labels and thresholds were built from weekly bars aggregated from discovery daily_ohlc through 2026-06-12. Selected-security right-rail charts call the report API with as_of=latest; refresh setup levels before using static thresholds as current trading evidence. Fundamental claims route to the LEU, CCJ, and BWXT security lanes, the parent nuclear-power map, official DOE/NRC/EIA sources, and company releases listed below.

Basket

The basket is inherited from the parent nuclear-power map and hand-curated with linked knowledge coverage, official company releases, SEC companyfacts, and read-only discovery checks. Ranking uses direct node economics and source-backed exposure first, funding and contract proof second, and technical timing last. ASPI stays chartable but speculative; Silex/GLE stays an off-grid watch row because the business fit is direct but this checkout has no maintained local OHLC route.

LEU Centrus Energy

Direct U.S. enrichment and HALEU route where policy scarcity can become SWU sales, DOE work, backlog, and capacity funding.

Market cap$3.2B
Next earningsAug 4, 2026 est.
Latest qtr revenue$76.7M

Role in stack

Centrus sells SWU, uranium, and enriched uranium product to utilities and houses DOE-backed HALEU engineering and manufacturing work in Technical Solutions. Theme pressure becomes economics through LEU deliveries, HALEU task orders, partner contracts, capacity funding, and commercial-scale enrichment execution.

Revenue mix

Q1 2026 revenue was $44.6M from LEU and $32.1M from Technical Solutions. The LEU segment produced most gross profit, while Technical Solutions carries the HALEU and domestic-capacity buildout path.

Latest qtr revenue

Q1 2026 total revenue was $76.7M for the three months ended March 31, 2026, per Centrus's May 5, 2026 release. Revenue quality still depends on DOE task-order finalization, Russian supply access, 2026 capex, and cash-burn control.

CCJ Cameco

Scaled fuel-cycle platform with current uranium, conversion, fuel-services, Westinghouse, and GLE exposure.

Market cap$44.0B
Next earningsJul 30, 2026 est.
Latest qtr revenueC$845M

Role in stack

Cameco owns uranium production, Blind River refining, Port Hope conversion, fuel-services capacity, Westinghouse exposure, and a 49% GLE stake. The node converts through realized uranium prices, UF6/UO2 conversion, fuel-services volume, Westinghouse cash value, and GLE licensing progress.

Revenue mix

Q1 2026 revenue was led by uranium at C$712M and fuel services at C$134M. Fuel services produced 3.3M kgU, sold 2.8M kgU, and generated C$54M of adjusted EBITDA.

Latest qtr revenue

Q1 2026 consolidated revenue was C$845M for the three months ended March 31, 2026, per Cameco's Q1 2026 release. The node-specific caveat is that uranium and Westinghouse dominate valuation while conversion and fuel services are only one part of the platform.

BWXT BWX Technologies

Nuclear manufacturing and fuel-adjacent fabrication route with stronger backlog proof than direct HALEU exposure.

Market cap$17.7B
Next earningsAug 3, 2026 est.
Latest qtr revenue$860.2M

Role in stack

BWXT supplies naval reactors, special materials, advanced reactor work, commercial nuclear components, fuel handling, services, and fuel-adjacent manufacturing. Theme pressure becomes economics through funded orders, backlog conversion, Commercial Operations margin, PCG capacity, and customer-backed fuel or fabrication programs.

Revenue mix

Q1 2026 revenue split between Government Operations at $577.9M and Commercial Operations at $283.6M. Government nuclear work anchors the company, while Commercial Operations carries more of the commercial fuel, components, and services optionality.

Latest qtr revenue

Q1 2026 revenue was $860.2M for the three months ended March 31, 2026, per BWXT's May 4, 2026 release. The node-specific caveat is that enrichment and HALEU are less direct to BWXT than backlog, naval awards, commercial nuclear manufacturing, and margin conversion.

ASPI ASP Isotopes

Speculative U.S. isotope and enrichment tail through Quantum Leap Energy, planned LEU/HALEU work, and regulatory milestones.

Market cap$0.8B
Next earningsNot confirmed
Latest qtr revenue$4.18M

Role in stack

ASP Isotopes and Quantum Leap Energy are trying to move from isotope separation and project announcements into U.S. conversion, enrichment, HALEU, LEU+, and deconversion capacity. The gate is official licensing, technology proof, customer offtake, funded construction, and disclosed unit economics.

Revenue mix

The current public filing mix is not a mature fuel-cycle revenue base. SEC companyfacts show Q1 2026 revenue of $4.18M, while the fuel-cycle thesis still depends on future QLE projects rather than current commercial enrichment revenue.

Latest qtr revenue

SEC companyfacts for ASPI show Q1 2026 revenue of $4.18M for the three months ended March 31, 2026, filed May 20, 2026. Nasdaq/Zacks did not provide an upcoming earnings date in the June 13, 2026 check.

SILXY / SLX.AX Silex Systems / Global Laser Enrichment

Direct laser-enrichment watch row through Silex's GLE ownership, but local OHLC coverage is missing.

Market capNot local
Next earningsNot confirmed
Latest qtr revenueNot local

Role in stack

Silex owns 51% of Global Laser Enrichment, which is pursuing SILEX laser-enrichment technology, Paducah licensing, tails re-enrichment, LEU, LEU+, and HALEU paths. The gate is NRC licensing, technology readiness, funding, customer commitments, and royalty or equity economics.

Revenue mix

No local discovery or linked knowledge lane supports a current segment or revenue mix for SILXY / SLX.AX in this checkout. Treat the row as enrichment-technology routing context, not a current underwriting row.

Latest qtr revenue

Not available locally. Add maintained local coverage or a bounded official-source check before using Silex/GLE quarterly revenue, market cap, or chart evidence in the ranked basket.

Market caps are close-derived local estimates using discovery daily_ohlc close and weighted shares on 2026-06-12: LEU $3.2B, CCJ $44.0B, BWXT $17.7B, and ASPI $0.8B. Next-earnings dates for LEU, CCJ, and BWXT are Nasdaq/Zacks algorithmic estimates checked on 2026-06-13; ASPI had no Nasdaq/Zacks date, and Silex/GLE was not checked because no local ticker route exists. Latest-quarter revenue sources are the company Q1 2026 releases for LEU, CCJ, and BWXT and SEC companyfacts for ASPI.

What Confirms Or Weakens

Area What confirms What weakens or invalidates Watch next
01 Node thesis Fuel bottleneck becomes revenue
What confirms

DOE HALEU awards, utility enrichment contracts, HALEU allocation, and domestic capacity funding move from announcements to licensed operating milestones and recognized revenue.

What weakens or invalidates

DOE awards slip, Russian-supply waivers soften near-term scarcity, advanced-reactor fuel demand moves out, or customer commitments stay contingent on future funding.

Watch next
  • DOE HALEU updates
  • Utility SWU contracts
  • NRC fuel-cycle licensing
  • Russian LEU waivers
02 Economics Backlog and margin conversion
What confirms

LEU backlog converts to revenue and operating cash flow; CCJ fuel-services EBITDA stabilizes; BWXT fuel and fabrication work becomes material to backlog, segment margin, and FCF.

What weakens or invalidates

Capex overruns, negative cash burn, weak segment margins, small fuel revenue, or non-GAAP adjustments absorb the benefit from policy support and customer demand.

Watch next
  • LEU revenue and capex guide
  • CCJ fuel-services EBITDA
  • BWXT Commercial margin
  • Fuel contract disclosures
03 Customer DOE and utility demand quality
What confirms

Named utility, DOE, or reactor customer commitments include volumes, funding, delivery dates, qualification requirements, and terms that can support capacity investment.

What weakens or invalidates

Demand stays in MOUs, studies, allocations, pilot programs, or press releases without binding offtake, customer credit, or delivery obligations.

Watch next
  • LEU contingent backlog terms
  • HALEU allocation process
  • Advanced-reactor fuel specs
  • Utility procurement data
04 Funding and policy Capital support and import rules
What confirms

Appropriations, DOE task-order funding, private offtake, and Russian LEU import restrictions support domestic capacity without forcing excessive equity dilution.

What weakens or invalidates

Funding gaps, waiver extensions, high-cost financing, convert or equity issuance, or policy delays shift the economics away from public shareholders.

Watch next
  • Public Law 118-62 waivers
  • DOE task-order funding
  • LEU cash burn
  • ASPI/QLE financing
05 Operating and supply constraint Licensing and delivery path
What confirms

Licensing, procurement, construction, centrifuge manufacturing, conversion reliability, fuel qualification, and delivery milestones progress with disclosed cost and schedule control.

What weakens or invalidates

Licensing delays, technology proof failure, Port Hope renewal risk, supplier bottlenecks, construction slippage, or fuel qualification failures push the cash-flow window out.

Watch next
  • LEU Oak Ridge/Piketon milestones
  • CCJ Port Hope renewal
  • GLE Paducah licensing
  • BWXT capacity and PCG
06 Stale condition Refresh trigger
What confirms

Company filings, DOE/NRC/EIA policy sources, earnings-date checks, revenue sources, and local OHLC remain current after material awards, licensing, earnings, and price updates.

What weakens or invalidates

OTC coverage stays missing for Silex/GLE, ASPI tail claims lack official support, a new filing or DOE notice arrives, or report-API charts move beyond static setup thresholds.

Watch next
  • Discovery coverage
  • Knowledge lane dates
  • DOE/NRC releases
  • API chart freshness

Source Trail

Theme And Sector Routes

Security Lanes

  • LEU security lane for Centrus enrichment, HALEU, backlog, DOE award exposure, capacity funding, cash, debt, capex, and execution risk.
  • CCJ security lane for Cameco uranium, conversion, fuel services, Westinghouse, GLE optionality, Port Hope, margins, and valuation.
  • BWXT security lane for nuclear manufacturing, fuel-adjacent fabrication, government nuclear work, Commercial Operations, backlog, margin, FCF, and valuation proof burden.
  • ASPI has local price history and recent provider filing lookup coverage, but no maintained security lane in this checkout. Tail claims should stay tied to official filings and company releases.
  • SILXY / SLX.AX has no local discovery coverage in this checkout. It stays in watch status until there is a maintained local data route or another explicit chart source.

Policy, Regulatory, And Industry Sources

Company And Tail Sources

Earnings Date And Revenue Sources

  • Next-earnings estimates were checked on 2026-06-13 through Nasdaq API endpoints /api/analyst/LEU/earnings-date, /api/analyst/CCJ/earnings-date, /api/analyst/BWXT/earnings-date, and /api/analyst/ASPI/earnings-date. Nasdaq states the dates are Zacks algorithmic estimates based on historical reporting dates, so LEU, CCJ, and BWXT cards label them as estimates.
  • Estimated next earnings: LEU Aug 4, 2026; CCJ Jul 30, 2026; BWXT Aug 3, 2026. Nasdaq/Zacks did not provide an ASPI date; Silex/GLE has no local route and was left Not confirmed.
  • Latest-quarter revenue references: LEU Q1 2026 revenue $76.7M from Centrus's May 5, 2026 release; CCJ Q1 2026 consolidated revenue C$845M from Cameco's Q1 2026 release; BWXT Q1 2026 revenue $860.2M from BWXT's May 4, 2026 release; ASPI Q1 2026 revenue $4.18M from SEC companyfacts filed May 20, 2026. Silex/GLE latest-quarter revenue is not available locally.

Discovery And Chart Provenance

  • Read-only discovery checks used python -m discovery.cli status for LEU, CCJ, BWXT, and ASPI plus read-only DuckDB queries against daily_ohlc and instruments. Local daily bars cover LEU, CCJ, BWXT, and ASPI through 2026-06-12; SILXY / SLX.AX has no local daily_ohlc rows.
  • Weekly OHLC for selected-security charts is derived from daily rows by calendar week: first open, maximum high, minimum low, final close, and summed volume. Chart packages use a three-year visible horizon, 20-week EMA, 100-week EMA where enough history exists, and weekly volume.
  • Static setup labels retained from the prior node build: LEU below key trend; CCJ base forming; BWXT base forming; ASPI speculative tail above moving averages; Silex/GLE off-grid watch. The selected-security right rail uses /api/securities/{ticker}/chart?frequency=weekly&window=3y&as_of=latest.
  • Representative API validation was attempted against http://127.0.0.1:8765/api/securities/LEU/chart?frequency=weekly&window=3y&as_of=latest. During review, python -m api.run started uvicorn on 127.0.0.1:8765, but sandboxed loopback HTTP requests were blocked or could not connect. Static API attributes, chart triggers, route metadata, and absence of embedded OHLC payloads were verified; live HTTP chart rendering remains unverified.

Categories